ITRM INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Has Been Filed Against Iterum Therapeutics plcPRNewsWire • 08/16/21
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Iterum Therapeutics plc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ITRMPRNewsWire • 08/15/21
ALERT: Investors with Substantial Losses Have Opportunity to Lead the Iterum Therapeutics plc Class Action Lawsuit - ITRMNewsfile Corp • 08/14/21
DEADLINE FOR ITRM INVESTORS: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Has Been Filed Against Iterum Therapeutics plcNewsfile Corp • 08/14/21
ITRM Breaking Alert: Nationally Ranked Rosen Law Firm Encourages Iterum Therapeutics plc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ITRMNewsfile Corp • 08/13/21
Iterum Therapeutics plc (ITRM) CEO Corey Fishman on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/13/21
SHAREHOLDER ALERT: Robbins LLP Announces that Iterum Therapeutics PLC (ITRM) is Being Sued for Misleading ShareholdersBusiness Wire • 08/13/21
Iterum Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 08/13/21
ITRM NOTICE: Investors with Substantial Losses Have Opportunity to Lead the Iterum Therapeutics plc Class Action LawsuitBusiness Wire • 08/12/21
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Iterum Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 08/12/21
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CCIV, AHCO and ITRMAccesswire • 08/12/21
ONGOING INVESTIGATION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Iterum Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 08/11/21
ROSEN, A LEADING LAW FIRM, Encourages Iterum Therapeutics plc Investors with Losses to Secure Counsel Before Important Deadline - ITRMPRNewsWire • 08/10/21
INVESTIGATION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Iterum Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 08/10/21
ITRM Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Iterum Therapeutics plc Shareholders of Class Action and Encourages Investors to Contact the FirmPRNewsWire • 08/10/21
INVESTIGATION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Iterum Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 08/09/21
ITERUM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Iterum Therapeutics plc and Encourages Investors to Contact the FirmBusiness Wire • 08/07/21
ITRM ALERT: Investors with Substantial Losses Have Opportunity to Lead the Iterum Therapeutics plc Class Action LawsuitBusiness Wire • 08/06/21
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Iterum Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 08/06/21
ITRM INVESTOR ALERT: Rosen Law Firm Encourages Iterum Therapeutics plc Investors with Losses Over $100K to Secure Counsel Before Important Deadline – ITRMBusiness Wire • 08/06/21
Iterum Therapeutics to Provide Business Update and Report Second Quarter 2021 Financial Results on August 13, 2021GlobeNewsWire • 08/06/21
Iterum Therapeutics PLC (ITRM) Loses 67.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 07/29/21
